Preimplantation genetic testing for aneuploidy: challenges in clinical practice
Tóm tắt
Preimplantation genetic testing for aneuploidy (PGT-A) has been used widely during in vitro fertilization procedures in assisted reproductive centers throughout the world. Despite its wide use, concerns arise from the use of PGT-A technology in clinical decision-making. We address knowledge gaps in PGT-A, summarizing major challenges and current professional guidelines. First, PGT-A is a screening test and not a diagnostic test. Second, mosaicism is much higher in the blastocyst stage from PGT-A than had been recognized previously and a mosaic embryo may not accurately represent the genetic disease risk for future fetal disorders. Third, PGT-A was not validated clinically before use in patients; the best use of this technology for selected age-groups remains uncertain. Given these gaps, we believe that current professional policies relying on industry-self-regulation are insufficient. In the USA, the Food and Drug Administration may be the most appropriate agency to provide more definitive guidelines and regulations that are needed for better practice.
Tài liệu tham khảo
Carvalho F, Coonen E, Goossens V, et al. ESHRE PGT consortium good practice recommendations for the organisation of PGT. Hum Reprod Open. 2020;2020(3):hoaa021.
Harper JC. Preimplantation genetic screening. J Med Screen. 2018;25(1):1–5.
Wilkins-Haug L, Amor DJ, Savulescu J. ISPD 2021 debate - All in vitro fertilization cycles should involve pre-implantation genetic testing to improve fetal health and pregnancy outcomes. Prenat Diagn. 2022;42(8):1015–21.
Gleicher N, Patrizio P, Brivanlou A. Preimplantation genetic testing for aneuploidy—a castle built on sand. Trends Mol Med. 2021;27(8):731–42.
Greco E, Litwicka K, Minasi MG, Cursio E, Greco PF, Barillari P. Preimplantation genetic testing: where we are today. Int J Mol Sci. 2020;21(12):4381.
Practice Committee of Society for Assisted Reproductive T, Practice Committee of American Society for Reproductive M. Preimplantation genetic testing: a Practice Committee opinion. Fertil Steril. 2009;90(5):136–43.
Bayefsky M. Who should regulate preimplantation genetic diagnosis in the United States? AMA J Ethics. 2018;20(12):E1160-1167.
Zuckerman S, Gooldin S, Zeevi DA, Altarescu G. The decision-making process, experience, and perceptions of preimplantation genetic testing (PGT) users. J Assist Reprod Genet. 2020;37(8):1903–12.
Neumann K, Griesinger G. An economic analysis of aneuploidy screening of oocytes in assisted reproduction in germany. Geburtshilfe Frauenheilkd. 2020;80(2):172–8.
Neumann K, Sermon K, Bossuyt P, et al. An economic analysis of preimplantation genetic testing for aneuploidy by polar body biopsy in advanced maternal age. BJOG. 2020;127(6):710–8.
Lee M, Lofgren KT, Thomas A, et al. The cost-effectiveness of preimplantation genetic testing for aneuploidy in the United States: an analysis of cost and birth outcomes from 158,665 in vitro fertilization cycles. Am J Obstet Gynecol. 2021;225(1):55.e51-55.e17.
Scott RT Jr, Ferry K, Su J, Tao X, Scott K, Treff NR. Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study. Fertil Steril. 2012;97(4):870–5.
Tiegs AW, Tao X, Zhan Y, et al. A multicenter, prospective, blinded, nonselection study evaluating the predictive value of an aneuploid diagnosis using a targeted next-generation sequencing-based preimplantation genetic testing for aneuploidy assay and impact of biopsy. Fertil Steril. 2021;115(3):627–37.
Coticchio G, Barrie A, Lagalla C, et al. Plasticity of the human preimplantation embryo: developmental dogmas, variations on themes and self-correction. Hum Reprod Update. 2021;27(5):848–65.
Practice Committee and Genetic Counseling Professional Group (GCPG) of the American Society for Reproductive Medicine. Clinical management of mosaic results from preimplantation genetic testing for aneuploidy (PGT-A) of blastocysts: a committee opinion. Fertil Steril. 2020;114(2):246–54.
Viotti M, McCoy RC, Griffin DK, et al. Let the data do the talking: the need to consider mosaicism during embryo selection. Fertil Steril. 2021;116(5):1212–9.
Zwingerman R, Langlois S. Committee opinion No. 406: prenatal testing after IVF with preimplantation genetic testing for aneuploidy. J Obstet Gynaecol Can. 2020;42(11):1437-1443.e1431.
Viotti M, Victor AR, Barnes FL, et al. Using outcome data from one thousand mosaic embryo transfers to formulate an embryo ranking system for clinical use. Fertil Steril. 2021;115(5):1212–24.
Kerubo J. After Genetic Testing, I Took a Chance on an ‘Imperfect’ Pregnancy. April 6, 2021; https://www.nytimes.com/2021/04/06/well/family/in-vitro-fertilization-mosaic-embryo.html
McGowan R, Pilipenko V, Smolarek TA, West E, Tolusso LK. Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics. Fertil Steril. 2020;114(1):110–7.
Capalbo A, Poli M, Jalas C, Forman EJ, Treff NR. On the reproductive capabilities of aneuploid human preimplantation embryos. Am J Hum Genet. 2022;109(9):1572–81.
Paulson RJ, Treff NR. Isn’t it time to stop calling preimplantation embryos “mosaic”? F S Rep. 2020;1(3):164–5.
Roche K, Racowsky C, Harper J. Utilization of preimplantation genetic testing in the USA. J Assist Reprod Genet. 2021;38(5):1045–53.
Simopoulou M, Sfakianoudis K, Maziotis E, et al. PGT-A: Who and when? Α systematic review and network meta-analysis of RCTs. J Assist Reprod Genet. 2021;38(8):1939–57.
Theobald R, SenGupta S, Harper J. The status of preimplantation genetic testing in the UK and USA. Hum Reprod. 2020;35(4):986–98.
Hecker A. What Should I Do with My Unused Embryos. April 15, 2020; https://www.nytimes.com/2020/04/15/parenting/fertility/ivf-unused-frozen-eggs.html
Preimplantation Genetic Testing. ACOG committee opinion, number 799. Obstet Gynecol. 2020;135(3):e133–7.
Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. The use of preimplantation genetic testing for aneuploidy (PGT-A): a committee opinion. Fertil Steril. 2018;109(3):429–36.
Early ML, Kumar P, Marcell AV, Lawson C, Christianson M, Pecker LH. Literacy assessment of preimplantation genetic patient education materials exceed national reading levels. J Assist Reprod Genet. 2020;37(8):1913–22.
Calhaz-Jorge C, De Geyter CH, Kupka MS, et al. Survey on ART and IUI: legislation, regulation, funding and registries in European countries: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod Open. 2020;2020(1):hoz044.
Ginoza MEC, Isasi R. Regulating preimplantation genetic testing across the world: a comparison of international policy and ethical perspectives. Cold Spring Harb Perspect Med. 2020;10(5):a036681.
Carvalho F, Moutou C, Dimitriadou E, et al. ESHRE PGT Consortium good practice recommendations for the detection of monogenic disorders. Hum Reprod Open. 2020;2020(3):hoaa018.
Coonen E, Rubio C, Christopikou D, et al. ESHRE PGT Consortium good practice recommendations for the detection of structural and numerical chromosomal aberrations. Hum Reprod Open. 2020;2020(3):hoaa017.
Consortium EP, Group SI-EBW, Kokkali G, et al. ESHRE PGT Consortium and SIG Embryology good practice recommendations for polar body and embryo biopsy for PGT. Hum Reprod Open. 2020;2020(3):hoaa020.
Alon I, Urbanos-Garrido R, Guimón J. Regulating reproductive genetic services: dealing with spiral-shaped processes and techno-scientific imaginaries. J Assist Reprod Genet. 2021;38(2):305–17.
Bracewell-Milnes T, Saso S, Jones B, et al. A systematic review exploring the patient decision-making factors and attitudes towards pre-implantation genetic testing for aneuploidy and gender selection. Acta Obstet Gynecol Scand. 2021;100(1):17–29.